Quote Originally Posted by numbere View Post
I understand your point and it makes since in theory.

However, common since can't be applied in all situations.

I'm 100% sure that the gw researchers took the dosing into account when they ran their models and presented their data to their superiors.

I'm sure the people in charge of distributing research funding took into account the dosing when they pulled funding for a drug the showed positive benefits.

The people who develop these drugs are brilliant and graduate at the top of their class. They know much more than we ever will about how these drugs will affect the body.

Pharmaceutical companies do not pull funding for a drug unless they have a very good reason, especially when the drug shows promise.
This is so true. If a company has a product that shows some promise, they're not going to pull it for small side effects. When you consider the amount of money that can be made on a promising weightloss drug, the fact that they pulled it speeks volumes. In America where obesity is one of the biggest health concerns, this product potentially could have been their number one seller. I knew it was pulled, and if I would have thought about it I never would have wasted the money on it.